Adding pathways adds mechanisms: tirzepatide outperforms semaglutide because two pathways work better than one, and retatrutide may outperform tirzepatide because three pathways address both caloric intake (appetite) and caloric output (energy expenditure) simultaneously
So, we know a lot more about diabetes and heart disease, but what people dont know so much is that obesity is linked to at least 13 cancers and probably more, said Liza Makowski in her lab where for almost a decade, shes studied the connection between cancer and obesity
The mainstream copper-biology research community and the broader peptide research community have engaged with the GHK-Cu literature at various points, but the depth of independent characterization outside the Pickart-affiliated research has been variable
Daima, Engineered nanomaterials for biomedical applications and their toxicity: a review
Any concerns about side effects should be discussed with your healthcare provider, who can help weigh the benefits and risks of continuing treatment and explore alternative management strategies if necessary
